Development in Medical News

U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products

The U.S. Navy has awarded two additional contracts to the RTP, NC-based life sciences company Entegrion, Inc., for implementation of the company's proprietary technologies to improve the safety and availability of blood-derived products for treating combat injuries. Recent medical research has d...

Industry And FDA Leaders To Discuss The Evolving Science Of Cardiovascular Safety (CV) And Diabetic Drug Development

The Drug Information Association (DIA) will host a two-day workshop on Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications from September 23-24, 2009 in Washington, DC. Horsham, PA, (PRWEB) July 29, 2009 -- The Drug Information Association (D...

Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases

NEW YORK, July 28 /PRNewswire-USNewswire/ -- A record 488 new, innovative medicines are being developed by biopharmaceutical research companies with facilities in New York City, according to a new report released today at the Bronx-Lebanon Medical Center. The medicines are awaiting app...

NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test

FT. MYERS, Fla., July 24 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services announced today that it has entered into a Strategic Supply Agreement with Abbott (NYSE: ABT ). The Agreement provides for Abbott t...

Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery

PITTSBURGH, July 24 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing snake robot technologies for use in a wide range of surgical and interventional applications has closed on an $11.6 Million private equity Series A round of financing. The round was led by Eagle Vent...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management

Oldsmar, Fla., July 22, /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation today announced a research and development collaboration agreement with nationally recognized ...

Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments

CAPE TOWN, South Africa, July 21 /PRNewswire-USNewswire/ -- In an unprecedented and historic show of unity, advocates for all the health Millennium Development Goals (MDGs) have charged the leaders of G-8 countries with reneging on their commitments to health by chronicall...

Mindray Medical Provides Mid-Year Update on Product Development and GPO Contracts

SHENZHEN, China, July 16 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR , the Company), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches and GPO relationships for the first half of 200...

Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc.

CHICAGO, July 16 /PRNewswire/ -- Water Street Healthcare Partners , a leading private equity firm focused exclusively on the health care industry, announced today that it has acquired the Pharmaceutical Development division from AAIPharma Inc . Water Street has...

New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors' Offices

WHITE PLAINS, N.Y., July 14 /PRNewswire-USNewswire/ -- A new electronic tool that will put family medical history at doctors' fingertips - alerting them to a patient's increased risk for birth defects or pregnancy complications - will be developed through a three-year cooperative ag...

Sysmex America Names Industry Veteran to Business Development Post

MUNDELEIN, Ill., July 10 /PRNewswire/ -- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced the appointment of Jim Cusack as Director of Business Development and Strategic Alliances, said Ralph Taylor, Vice President of Mar...

New role discovered for molecule important in development of the pancreas

PHILADELPHIA For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer. A protein, whose role in pancreatic development has long been recognized, has been discovered to play an additiona...

Korea Health Industry Development Institute, Be Ready for attracting Patients in States (Hold Korea Global Healthcare Conference with CKMP)

Korea Health Industry Development Institute (President Kim, Bup-Wan, KHIDI) and Council for Korea Medicine Overseas Promotion (President Sung, Sangchul, CKMP) will hold Korea Global Healthcare Conference to make promotion and exposure to attract patients in U.S. from July 16 to 18, 2009 in New Yo...

KePRO Names Two New Business Development Directors

Bonnie Yanelli and Joe Krolac to support KePRO's business expansion efforts Harrisburg, PA (Vocus) July 7, 2009 -- KePRO , a leading quality improvement and care management organization, named Bonnie Yanelli and Joseph Krolak as Business Development Directors. They wil...

Major Firms Eyeing CBMS Development of New Glaucoma Treatment

NEW YORK, MONTREAL and SAN DIEGO, CA, July 7 /PRNewswire-FirstCall/ - Canadian Bio Med Systems Inc., a subsidiary of ICBS Ltd., (OTCPK: ICBT), and Ocular Therapeutics Inc. of San Diego California, announced that Ocular Therapeutics has signed non-disclosure agreements with two of the largest pharm...

NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs

NEW YORK, July 6 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has appointed Alan G. Harris, M.D., Ph.D., FACP, FRCP, as the Company's Vice Pre...

Rising Financial Solutions Taps Director of Business Development for Medicare Set Aside Administration Offerings

CHICAGO, June 29 /PRNewswire/ -- Rising Financial Solutions, LLC, a medical-financial management company and wholly-owned subsidiary of Rising Medical Solutions, Inc., is pleased to announce the appointment of Hany Abdelsayed as the Director of Business Development for its Medicare Set Aside (MS...

Omega-3 Fatty Acids Key to Fetal Development - Possible Mercury Contamination Concerns in Some Fish Oil Avoided With Plant-based DHA in PreNexa(R) Prenatal Vitamins

MAPLE GROVE, Minn., June 25 /PRNewswire/ -- Leading experts specifically recommend Docosahexaenoic acid (DHA) as a key omega-3 fatty acid for prenatal development(1, 2, 3). DHA, derived from plants or fish, is consumed in the form of food or nutritional supplements. However, there is increasing ...

Go Healthy Announces Association With Business Development Firm

SPRING, Texas, June 23 /PRNewswire-FirstCall/ -- Go Healthy, Inc. (Pink Sheets: GOHE) announced today that the company has established a new association with a business development firm. The firm, Lonnie T. Morgan, Esq. of Minneapolis, Minnesota, brings a wealth of experience and expertise with v...

Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment

MENLO PARK, Calif., June 22 /PRNewswire/ -- Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, announced today that it has closed a $35 million Series B round and is continuing the rapid development of its Transcend CyP...

Data Development Worldwide Helps Pharmaceutical Marketers Optimize Relationship Marketing to Patients

Patient-360(TM) tool optimizes impact of patient education programs. NEW YORK, June 22 /PRNewswire/ -- For marketers in the pharmaceutical industry, building relationships directly with patients is a complex process. Data Development Worldwide's Patient-360(TM) market research tool allows ph...

Accelerated Development of New Treatment for Multi Drug-Resistant Tuberculosis: TB Alliance and Tibotec Announce Unique Partnership to Develop TMC207

SEATTLE, June 17 /PRNewswire/ -- When: Wednesday, June 17, 2009, 10:30am Eastern (9:30am Central; 8:30am Mountain; 7:30am Pacific) Dial-in: 1-877-879-6184 (toll-free) 1-719-325-4759 (local access) Conference Title: TB Alliance/Tibotec Briefing...

Particle Sciences Further Expands Combination Product Development Capabilities

BETHLEHEM, Pa., June 16 /PRNewswire/ -- Particle Sciences Inc., a leading service provider for the development of thermoplastic based Combination Products (drug-eluting devices), has further expanded their development and pilot production capabilities with the addition of a Leistritz ZSE-18mm twin...

AlphaRx and Gaia BioPharma Provide GAI-122 Development Update

GAI-122, an investigational injectable nano-emulsion formulated with AlphaRx's proprietary drug delivery technology, provides significant neuroprotection in animal behavioral models. Gaia BioPharma plans to initiate a clinical development program to further study GAI-122 for an ...

Nuvo Research and Covidien sign U.S. license and development agreement for Pennsaid(R) and Pennsaid Plus(R)

MISSISSAUGA, ON, June 16 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI) a Canadian drug development company focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery technologies, today announced that it has e...

Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts

SAN FRANCISCO, June 15 /PRNewswire-FirstCall/ -- Early results from the second series of trials have demonstrated a 5 log reduction (99.999%) in Pseudomonas aeruginousa and a 4.4 log reduction (99.994%) in Methicillin Resistant Staph Aureus (MRSA). Both of these pathogens are of major concern to m...

Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer

RARITAN, N.J., June 4 /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., today announced that it has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), with S...

Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

ProLindac Showing High DACH Platinum Activity; Drug Well Tolerated With No Signs of Acute Neurotoxicity DALLAS, June 1 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC . ( http://www.accesspharma.com ) (OTC Bulletin Board: ACCP), provided an update today on the progress ...

BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research

Special Order BD LSRFortessa(TM) Benchtop Flow Cytometry System Supports up to Five Lasers and 18 Colors Simultaneously SAN JOSE, Calif., June 1 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of the new special order BD LSRFortes...

Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today announced a presentation entitled "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers" at the Late Stage Industry Clinical Trials...

Intercell to Webcast Research & Development Day on Thursday, June 4, 2009

VIENNA and GAITHERSBURG, Md., May 27 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that it will webcast its Research & Development Day being held in New York on Thursday, June 4 starting at 12:00 p.m. Eastern Time (6 pm CET, 5 pm GMT). "This year's meeting will focus on the app...

Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology

WAYNE, N.J., May 22 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced that new data on Bayer's novel anti-cancer development candidate BAY 73-4506 (DAST-Inhibitor) will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fl...

New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes

RALEIGH, N.C., May 19 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) unveiled a new report today on medicines in the research pipeline for diabetes. The report shows that America's pharmaceutical research and biotechnology companies are testing a record...

New Report Released in North Carolina Shows Record Number of Medicines in Development to Treat Diabetes

RALEIGH, N.C., May 19 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) unveiled a new report today on medicines in the research pipeline for diabetes. The report shows that America's pharmaceutical research and biotechnology companies are testing a record...

Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators

LA JOLLA, Calif., May 18 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has further expanded the Company's executive team with the addition of Pratik Multani, M.D., M.S., as Vice President of Clinical Development. With more than a decade of clinical development experi...

MEI Development Corporation and GE Healthcare Sign Strategic Agreement

GE's Sole-Source Agreement Spans MEI's Broad Solution Offerings CORAL SPRINGS, Fla., May 18 /PRNewswire/ -- MEI Development Corporation (MEI), a subsidiary of The MEI Healthcare Group, announced today a strategic agreement with GE Healthcare (NYSE: GE ), a leading provider of healthcare te...

BioMarin Receives 2009 Corporate Award for the Development of Kuvan

National Organization for Rare Disorders (NORD) Recognizes BioMarin's Efforts to Expand Treatment Options for Patients with PKU NOVATO, Calif., May 15 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that it has received the 2009 Corporate Award from th...

Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis

NittoPhase™ HL Loaded up to 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields Oceanside, Calif. (PRWEB) May 15, 2009 -- Kinovate Life Sciences, Inc, the market leader in solid support for oligonucleotide synthesis, will be a...

Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research

COSTA MESA, Calif., May 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that the company has signed a Limited Purpose Cooperative Research and Development Agreement (LP-CRADA) with the Naval Medical Research Center (NMRC) and the Walter Reed Arm...

Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention

Senior Experts from Nordic Bioscience, Biomarker Strategies and Pharma on Panel WALTHAM, Mass., May 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI ) announced today that CEO Lewis H. Bender will moderate and co-present a panel discussion titled "Integrating Geneti...